Literature DB >> 33842985

MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities.

Yaoran Tu1, Yong Hu2.   

Abstract

MicroRNAs (miRNAs) are known as important regulators of gene expression and play important roles in diverse biological activities. However, the involvement of miRNAs in cerebral ischemia remains elusive. In the present study, using the middle cerebral artery occlusion (MCAO) model and oxygen-glucose deprivation/reperfusion (OGD/RP)-induced cell injury model, we found that the expression levels of miR-34c-5p were significantly reduced in MCAO rats and OGD/RP cells. Overexpression of miR-34c-5p could improve the increased brain infarction, brain water content and neurological scores in MCAO rats, as well as the abnormal expression of inflammatory cytokines (TNF-α, IL-6, COX-2, iNOS, IL-10) in OGD/RP cells. Moreover, overexpression of miR-34c-5p was found to inhibit the activity of nuclear factor-kappa B (NF-κB) by regulating the expression of nuclear receptor coactivator 1 (NCOA1), and increase the apoptotic rate of cortical neurons by inhibiting the expression of Caspase-3 and Bax and upregulating the expression of Bcl-2. Taken together, our findings demonstrated that miR-34c-5p plays an important role in cerebral ischemia/reperfusion injury, which may be mediated through inflammatory and apoptotic signaling pathways.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Cerebral ischemia; Inflammation; miR-34c-5p

Mesh:

Substances:

Year:  2021        PMID: 33842985     DOI: 10.1007/s11011-021-00724-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  22 in total

1.  Overexpression of miR-224-3p alleviates apoptosis from cerebral ischemia reperfusion injury by targeting FIP200.

Authors:  Yiming Deng; Gaoting Ma; Qihao Dong; Xuan Sun; Lian Liu; Zhongrong Miao; Feng Gao
Journal:  J Cell Biochem       Date:  2019-05-27       Impact factor: 4.429

2.  Prognostic Value of the Percentage of Neutrophils on Admission in Patients with ST-elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Min Men; Li Zhang; Tao Li; Baibing Mi; Tingzhong Wang; Yan Fan; Yuewu Chen; Guidong Shen; Lei Liang; Aiqun Ma
Journal:  Arch Med Res       Date:  2015-05-16       Impact factor: 2.235

3.  MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.

Authors:  Mikael Lerner; Josefin Lundgren; Shahab Akhoondi; Angelina Jahn; Hwee-Fang Ng; Farhad Akbari Moqadam; Joachim A F Oude Vrielink; Reuven Agami; Monique L Den Boer; Dan Grandér; Olle Sangfelt
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

4.  The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation.

Authors:  Ashraf Malhas; Nigel J Saunders; David J Vaux
Journal:  Cell Cycle       Date:  2010-02-01       Impact factor: 4.534

5.  Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.

Authors:  Serge Bracard; Xavier Ducrocq; Jean Louis Mas; Marc Soudant; Catherine Oppenheim; Thierry Moulin; Francis Guillemin
Journal:  Lancet Neurol       Date:  2016-08-23       Impact factor: 44.182

6.  MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia.

Authors:  XiaHeng Deng; Yun Zhong; LiZe Gu; Wei Shen; Jun Guo
Journal:  Brain Res Bull       Date:  2013-03-07       Impact factor: 4.077

7.  Cistanche deserticola polysaccharides protects PC12 cells against OGD/RP-induced injury.

Authors:  Yue Liu; Hui Wang; Mei Yang; Ning Liu; Yuping Zhao; Xue Qi; Yang Niu; Tao Sun; Yuxiang Li; Jianqiang Yu
Journal:  Biomed Pharmacother       Date:  2018-02-20       Impact factor: 6.529

8.  Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway.

Authors:  Zhigang Hu; Pengxin Zhao; Kaili Zhang; Leilei Zang; Haiying Liao; Weiyuan Ma
Journal:  Arch Biochem Biophys       Date:  2020-03-29       Impact factor: 4.013

9.  Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway.

Authors:  Guang-Qiang Hu; Xi Du; Yong-Jie Li; Xiao-Qing Gao; Bi-Qiong Chen; Lu Yu
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

10.  Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality.

Authors:  Jung Oh Kim; Jinkun Bae; Jinkwon Kim; Seung Hun Oh; Hui Jeong An; In Bo Han; Doyeun Oh; Ok Joon Kim; Nam Keun Kim
Journal:  J Stroke       Date:  2018-01-31       Impact factor: 6.967

View more
  5 in total

1.  Integrated Analysis and Identification of CSF-Derived Risk miRNAs and Pivotal Genes in Multiple Sclerosis.

Authors:  Yingchao Su; Zhihui Li; Xinming Rang; Yifei Wang; Jin Fu
Journal:  J Mol Neurosci       Date:  2022-07-11       Impact factor: 2.866

Review 2.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

Review 3.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

4.  CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5p.

Authors:  ZhenYu Shen; ShengHua Sun
Journal:  Onco Targets Ther       Date:  2021-09-10       Impact factor: 4.147

5.  Identification of programmed cell death-related gene signature and associated regulatory axis in cerebral ischemia/reperfusion injury.

Authors:  Jun Shu; Lu Yang; Wenshi Wei; Li Zhang
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.